Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast cream in atopic dermatitis long-term safety
NCT04804605Phase 3Completed
- Sponsor
- Arcutis Biotherapeutics
- Start
- Feb 2021
- Primary completion
- May 2024
- Countries
- 2
01
Overview
A Phase 3 trial of roflumilast vehicle cream in atopic dermatitis (AD), sponsored by Arcutis Biotherapeutics. Started Feb 2021; status: completed.
02
Drugs
roflumilast vehicle cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04804605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04804605.